Does the media favor OFIX or MMSI?

In the previous week, Orthofix Medical and Orthofix Medical both had 2 articles in the media. Merit Medical Systems' average media sentiment score of 0.97 beat Orthofix Medical's score of 0.56 indicating that Merit Medical Systems is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Orthofix Medical 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Merit Medical Systems 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to OMCL or OFIX?

In the previous week, Orthofix Medical had 1 more articles in the media than Omnicell. MarketBeat recorded 2 mentions for Orthofix Medical and 1 mentions for Omnicell. Orthofix Medical's average media sentiment score of 0.56 beat Omnicell's score of 0.50 indicating that Orthofix Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Omnicell 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Orthofix Medical 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation & earnings, OFIX or CNMD?

CONMED has higher revenue and earnings than Orthofix Medical. Orthofix Medical is trading at a lower price-to-earnings ratio than CONMED, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Orthofix Medical $822.31M 0.45 -$92.19M -$1.54 N/A CONMED $1.37B 1.01 $47.06M $1.85 25.05

Does the media prefer OFIX or CNMD?

In the previous week, Orthofix Medical and Orthofix Medical both had 2 articles in the media. Orthofix Medical's average media sentiment score of 0.56 beat CONMED's score of 0.23 indicating that Orthofix Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Orthofix Medical 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CONMED 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor IART or OFIX?

In the previous week, Integra LifeSciences had 25 more articles in the media than Orthofix Medical. MarketBeat recorded 27 mentions for Integra LifeSciences and 2 mentions for Orthofix Medical. Orthofix Medical's average media sentiment score of 0.56 beat Integra LifeSciences' score of 0.06 indicating that Orthofix Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Integra LifeSciences 1 Very Positive mention(s) 2 Positive mention(s) 13 Neutral mention(s) 8 Negative mention(s) 0 Very Negative mention(s) Neutral Orthofix Medical 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Orthofix Medical (OFIX) Competitors

$9.50 +0.41 (+4.51%)

Closing price 04:00 PM Eastern

Extended Trading

$9.50 0.00 (0.00%)

As of 04:10 PM Eastern

Compare

OFIX vs. MMSI, OMCL, CNMD, DRTS, and IART

Should you buy Orthofix Medical stock or one of its competitors? Orthofix Medical's main competitors and comparable companies include Merit Medical Systems (MMSI), Omnicell (OMCL), CONMED (CNMD), Alpha Tau Medical (DRTS), and Integra LifeSciences (IART). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment & supplies" industry.

How does Orthofix Medical compare to Merit Medical Systems?

Orthofix Medical (NASDAQ:OFIX) and Merit Medical Systems (NASDAQ:MMSI) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, dividends, profitability, risk, analyst recommendations, valuation, earnings and institutional ownership.

In the previous week, Orthofix Medical and Orthofix Medical both had 2 articles in the media. Merit Medical Systems' average media sentiment score of 0.97 beat Orthofix Medical's score of 0.56 indicating that Merit Medical Systems is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Orthofix Medical	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Merit Medical Systems	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Merit Medical Systems has higher revenue and earnings than Orthofix Medical. Orthofix Medical is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Orthofix Medical	$822.31M	0.45	-$92.19M	-$1.54	N/A
Merit Medical Systems	$1.52B	3.36	$128.49M	$2.42	35.28

Orthofix Medical has a beta of 0.62, suggesting that its share price is 38% less volatile than the broader market. Comparatively, Merit Medical Systems has a beta of 0.51, suggesting that its share price is 49% less volatile than the broader market.

Merit Medical Systems has a net margin of 9.22% compared to Orthofix Medical's net margin of -7.41%. Merit Medical Systems' return on equity of 13.75% beat Orthofix Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Orthofix Medical	-7.41%	-14.05%	-7.17%
Merit Medical Systems	9.22%	13.75%	8.10%

Orthofix Medical currently has a consensus target price of $14.75, suggesting a potential upside of 62.27%. Merit Medical Systems has a consensus target price of $100.00, suggesting a potential upside of 17.14%. Given Orthofix Medical's higher probable upside, equities research analysts plainly believe Orthofix Medical is more favorable than Merit Medical Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Orthofix Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Merit Medical Systems	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.83

89.8% of Orthofix Medical shares are held by institutional investors. Comparatively, 99.7% of Merit Medical Systems shares are held by institutional investors. 2.7% of Orthofix Medical shares are held by company insiders. Comparatively, 0.7% of Merit Medical Systems shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Merit Medical Systems beats Orthofix Medical on 13 of the 16 factors compared between the two stocks.

How does Orthofix Medical compare to Omnicell?

Omnicell (NASDAQ:OMCL) and Orthofix Medical (NASDAQ:OFIX) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, valuation, earnings, profitability and media sentiment.

Omnicell has a beta of 0.98, meaning that its stock price is 2% less volatile than the broader market. Comparatively, Orthofix Medical has a beta of 0.62, meaning that its stock price is 38% less volatile than the broader market.

In the previous week, Orthofix Medical had 1 more articles in the media than Omnicell. MarketBeat recorded 2 mentions for Orthofix Medical and 1 mentions for Omnicell. Orthofix Medical's average media sentiment score of 0.56 beat Omnicell's score of 0.50 indicating that Orthofix Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Omnicell	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Orthofix Medical	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

97.7% of Omnicell shares are owned by institutional investors. Comparatively, 89.8% of Orthofix Medical shares are owned by institutional investors. 2.9% of Omnicell shares are owned by insiders. Comparatively, 2.7% of Orthofix Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Omnicell currently has a consensus target price of $57.86, suggesting a potential upside of 72.19%. Orthofix Medical has a consensus target price of $14.75, suggesting a potential upside of 62.27%. Given Omnicell's stronger consensus rating and higher probable upside, equities analysts clearly believe Omnicell is more favorable than Orthofix Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Omnicell	0 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.78
Orthofix Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Omnicell has higher revenue and earnings than Orthofix Medical. Orthofix Medical is trading at a lower price-to-earnings ratio than Omnicell, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Omnicell	$1.18B	1.29	$2.05M	$0.84	40.00
Orthofix Medical	$822.31M	0.45	-$92.19M	-$1.54	N/A

Omnicell has a net margin of 3.13% compared to Orthofix Medical's net margin of -7.41%. Omnicell's return on equity of 5.66% beat Orthofix Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Omnicell	3.13%	5.66%	3.57%
Orthofix Medical	-7.41%	-14.05%	-7.17%

Summary

Omnicell beats Orthofix Medical on 14 of the 16 factors compared between the two stocks.

How does Orthofix Medical compare to CONMED?

Orthofix Medical (NASDAQ:OFIX) and CONMED (NYSE:CNMD) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, media sentiment, institutional ownership, earnings, profitability and dividends.

Orthofix Medical presently has a consensus price target of $14.75, suggesting a potential upside of 62.27%. CONMED has a consensus price target of $41.40, suggesting a potential downside of 10.67%. Given Orthofix Medical's stronger consensus rating and higher probable upside, research analysts plainly believe Orthofix Medical is more favorable than CONMED.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Orthofix Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
CONMED	1 Sell rating(s)	7 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.88

CONMED has a net margin of 4.12% compared to Orthofix Medical's net margin of -7.41%. CONMED's return on equity of 14.31% beat Orthofix Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Orthofix Medical	-7.41%	-14.05%	-7.17%
CONMED	4.12%	14.31%	6.33%

89.8% of Orthofix Medical shares are held by institutional investors. 2.7% of Orthofix Medical shares are held by insiders. Comparatively, 0.3% of CONMED shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

CONMED has higher revenue and earnings than Orthofix Medical. Orthofix Medical is trading at a lower price-to-earnings ratio than CONMED, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Orthofix Medical	$822.31M	0.45	-$92.19M	-$1.54	N/A
CONMED	$1.37B	1.01	$47.06M	$1.85	25.05

Orthofix Medical has a beta of 0.62, suggesting that its share price is 38% less volatile than the broader market. Comparatively, CONMED has a beta of 0.94, suggesting that its share price is 6% less volatile than the broader market.

In the previous week, Orthofix Medical and Orthofix Medical both had 2 articles in the media. Orthofix Medical's average media sentiment score of 0.56 beat CONMED's score of 0.23 indicating that Orthofix Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Orthofix Medical	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CONMED	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

CONMED beats Orthofix Medical on 9 of the 15 factors compared between the two stocks.

How does Orthofix Medical compare to Alpha Tau Medical?

Alpha Tau Medical (NASDAQ:DRTS) and Orthofix Medical (NASDAQ:OFIX) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their media sentiment, earnings, dividends, valuation, institutional ownership, profitability, risk and analyst recommendations.

Alpha Tau Medical has a beta of 1.22, suggesting that its share price is 22% more volatile than the broader market. Comparatively, Orthofix Medical has a beta of 0.62, suggesting that its share price is 38% less volatile than the broader market.

Alpha Tau Medical has higher earnings, but lower revenue than Orthofix Medical. Alpha Tau Medical is trading at a lower price-to-earnings ratio than Orthofix Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alpha Tau Medical	N/A	N/A	-$42.63M	-$1.04	N/A
Orthofix Medical	$822.31M	0.45	-$92.19M	-$1.54	N/A

Alpha Tau Medical presently has a consensus target price of $15.40, suggesting a potential upside of 4.27%. Orthofix Medical has a consensus target price of $14.75, suggesting a potential upside of 62.27%. Given Orthofix Medical's stronger consensus rating and higher probable upside, analysts clearly believe Orthofix Medical is more favorable than Alpha Tau Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alpha Tau Medical	2 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.38
Orthofix Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Alpha Tau Medical has a net margin of 0.00% compared to Orthofix Medical's net margin of -7.41%. Orthofix Medical's return on equity of -14.05% beat Alpha Tau Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alpha Tau Medical	N/A	-138.12%	-81.68%
Orthofix Medical	-7.41%	-14.05%	-7.17%

In the previous week, Orthofix Medical had 2 more articles in the media than Alpha Tau Medical. MarketBeat recorded 2 mentions for Orthofix Medical and 0 mentions for Alpha Tau Medical. Orthofix Medical's average media sentiment score of 0.56 beat Alpha Tau Medical's score of 0.00 indicating that Orthofix Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Alpha Tau Medical	Neutral
Orthofix Medical	Positive

2.7% of Alpha Tau Medical shares are owned by institutional investors. Comparatively, 89.8% of Orthofix Medical shares are owned by institutional investors. 39.5% of Alpha Tau Medical shares are owned by insiders. Comparatively, 2.7% of Orthofix Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Orthofix Medical beats Alpha Tau Medical on 9 of the 15 factors compared between the two stocks.

How does Orthofix Medical compare to Integra LifeSciences?

Integra LifeSciences (NASDAQ:IART) and Orthofix Medical (NASDAQ:OFIX) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, earnings, risk, profitability, analyst recommendations, institutional ownership, media sentiment and dividends.

Integra LifeSciences has a net margin of -0.44% compared to Orthofix Medical's net margin of -7.41%. Integra LifeSciences' return on equity of 18.30% beat Orthofix Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integra LifeSciences	-0.44%	18.30%	5.30%
Orthofix Medical	-7.41%	-14.05%	-7.17%

Orthofix Medical has lower revenue, but higher earnings than Integra LifeSciences. Integra LifeSciences is trading at a lower price-to-earnings ratio than Orthofix Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integra LifeSciences	$1.64B	0.60	-$516.47M	-$0.09	N/A
Orthofix Medical	$822.31M	0.45	-$92.19M	-$1.54	N/A

Integra LifeSciences has a beta of 1.21, suggesting that its share price is 21% more volatile than the broader market. Comparatively, Orthofix Medical has a beta of 0.62, suggesting that its share price is 38% less volatile than the broader market.

Integra LifeSciences currently has a consensus target price of $18.43, suggesting a potential upside of 45.34%. Orthofix Medical has a consensus target price of $14.75, suggesting a potential upside of 62.27%. Given Orthofix Medical's stronger consensus rating and higher possible upside, analysts clearly believe Orthofix Medical is more favorable than Integra LifeSciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integra LifeSciences	2 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.88
Orthofix Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

84.8% of Integra LifeSciences shares are owned by institutional investors. Comparatively, 89.8% of Orthofix Medical shares are owned by institutional investors. 3.8% of Integra LifeSciences shares are owned by company insiders. Comparatively, 2.7% of Orthofix Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, Integra LifeSciences had 25 more articles in the media than Orthofix Medical. MarketBeat recorded 27 mentions for Integra LifeSciences and 2 mentions for Orthofix Medical. Orthofix Medical's average media sentiment score of 0.56 beat Integra LifeSciences' score of 0.06 indicating that Orthofix Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Integra LifeSciences	1 Very Positive mention(s)	2 Positive mention(s)	13 Neutral mention(s)	8 Negative mention(s)	0 Very Negative mention(s)	Neutral
Orthofix Medical	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Integra LifeSciences beats Orthofix Medical on 9 of the 16 factors compared between the two stocks.

Get Orthofix Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OFIX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

OFIX vs. The Competition

Export

Metric	Orthofix Medical	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$387.14M	$5.52B	$7.17B	$13.38B
Dividend Yield	N/A	1.79%	2.53%	17.32%
P/E Ratio	-6.17	25.73	274.62	26.19
Price / Sales	0.47	42.39	608.28	90.56
Price / Cash	N/A	32.73	27.22	34.70
Price / Book	0.84	6.04	11.27	6.40
Net Income	-$92.19M	$146.97M	$3.49B	$381.07M
7 Day Performance	-3.40%	-0.82%	-1.59%	-0.56%
1 Month Performance	2.31%	-4.16%	-5.90%	-4.42%
1 Year Performance	-34.94%	2.52%	8.19%	1.89%

Orthofix Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
OFIX Orthofix Medical	2.6119 of 5 stars	$9.50 +4.5%	$14.75 +55.3%	-37.8%	$386.94M	$822.31M	N/A	1,605	Analyst Downgrade
MMSI Merit Medical Systems	3.4315 of 5 stars	$87.87 +1.0%	$100.00 +13.8%	+1.4%	$5.25B	$1.58B	36.31	7,500	Positive News
OMCL Omnicell	3.9039 of 5 stars	$34.31 +1.3%	$57.86 +68.6%	+8.6%	$1.56B	$1.18B	40.85	3,580
CNMD CONMED	1.8622 of 5 stars	$46.66 +0.4%	$41.40 -11.3%	-3.7%	$1.40B	$1.37B	25.22	3,900	News Coverage
DRTS Alpha Tau Medical	1.1213 of 5 stars	$15.19 +1.0%	$15.40 +1.4%	+242.7%	$1.37B	N/A	N/A	121	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:OFIX) was last updated on 10/5/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Orthofix Medical (OFIX) Competitors

OFIX vs. MMSI, OMCL, CNMD, DRTS, and IART

How does Orthofix Medical compare to Merit Medical Systems?

Summary

How does Orthofix Medical compare to Omnicell?

Summary

How does Orthofix Medical compare to CONMED?

Summary

How does Orthofix Medical compare to Alpha Tau Medical?

Summary

How does Orthofix Medical compare to Integra LifeSciences?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OFIX vs. The Competition

Orthofix Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Orthofix Medical (OFIX) Competitors

OFIX vs. MMSI, OMCL, CNMD, DRTS, and IART

How does Orthofix Medical compare to Merit Medical Systems?

Does the media favor OFIX or MMSI?

Which has better earnings and valuation, OFIX or MMSI?

Which has more volatility and risk, OFIX or MMSI?

Is OFIX or MMSI more profitable?

Do analysts prefer OFIX or MMSI?

Do insiders & institutionals hold more shares of OFIX or MMSI?

Summary

How does Orthofix Medical compare to Omnicell?

Which has more volatility and risk, OMCL or OFIX?

Does the media refer more to OMCL or OFIX?

Do institutionals and insiders hold more shares of OMCL or OFIX?

Do analysts prefer OMCL or OFIX?

Which has better earnings and valuation, OMCL or OFIX?

Is OMCL or OFIX more profitable?

Summary

How does Orthofix Medical compare to CONMED?

Do analysts rate OFIX or CNMD?

Is OFIX or CNMD more profitable?

Do institutionals & insiders hold more shares of OFIX or CNMD?

Which has stronger valuation & earnings, OFIX or CNMD?

Which has more volatility & risk, OFIX or CNMD?

Does the media prefer OFIX or CNMD?

Summary

How does Orthofix Medical compare to Alpha Tau Medical?

Which has more volatility & risk, DRTS or OFIX?

Which has preferable earnings and valuation, DRTS or OFIX?

Do analysts recommend DRTS or OFIX?

Is DRTS or OFIX more profitable?

Does the media favor DRTS or OFIX?

Do institutionals & insiders hold more shares of DRTS or OFIX?

Summary

How does Orthofix Medical compare to Integra LifeSciences?

Is IART or OFIX more profitable?

Which has stronger valuation & earnings, IART or OFIX?

Which has more volatility & risk, IART or OFIX?

Do analysts rate IART or OFIX?

Do insiders and institutionals hold more shares of IART or OFIX?

Does the media favor IART or OFIX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OFIX vs. The Competition

Orthofix Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools